PlainPharmaWatch

CMS Open Payments · Program Year 2024

TAS Medical, Inc.

TAS Medical, Inc. reported $33,817.24 across General Payments, Research, and Ownership to 298 physicians and teaching hospitals across 298 transactions.

See the rankings → How this is sourced
$33.8K
All-tracks total
298
Transactions
298
Recipients
#1448
of 1,925 companies

TAS Medical, Inc. reported $33,817.24 across all CMS Open Payments tracks (General + Research + Ownership) to 298 physicians and teaching hospitals in Program Year 2024 - ranking #1448 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $33,817.24, averaging $113.48 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer tas-medical-inc TAS Medical, Inc.

$33.8K · #1448/1,925 · 0.0% industry · PY2024

  • TOT $33.8K
  • RANK #1448
  • SHARE 0.0%
  • TXN 298
  • RCP 298
  • CAT 2
  • GEN $33.8K
  • TOP1 46.6%
  • PY 2024

Volume peers

Nearest volume peer: Prism Medical ($34.0K)

Cycle Pharmaceuticals Inc$34.4KZSFab, Inc.$34.3KGrifols Biologicals LLC$34.0KPrism Medical$34.0KTAS Medical, Inc. (this)$33.8K
All-tracks payment totals near TAS Medical, Inc. (CMS Open Payments PY2024)

TAS Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for TAS Medical, Inc.

TAS Medical, Inc. ranks #1448 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $33,817.24 across 298 transactions to 298 physicians and teaching hospitals - $113.48 per transaction and $113.48 per recipient on average.

288 transactions worth $20.8K make "Food and Beverage" the top general-payment category in the 2-category breakdown below, 61.6% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

TAS Medical, Inc. made 2 types of general payments. "Food and Beverage" is the largest category at $20.8K, 61.6% of General Payments.

How TAS Medical, Inc. divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$20.8K2. Consulting Fee$13.0K
Payment Type Amount Transactions
Food and Beverage $20.8K 288
Consulting Fee $13.0K 10

Recipient Concentration in General Payments

The five largest recipient relationships account for $21,498.08 (63.6%) of $33,817.24 in this company's General Payments records across 56 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for TAS Medical, Inc.

The five named recipients with the highest reported General Payments from this company

Michael Sawyer$15.8KDanielle Louise Cobb$1.5KDaryl S Marx$1.5KCarlos Egas$1.4KKarl Andrew LeBlanc$1.3K
  1. 1

    Michael Sawyer

    $15,775.34 across 44 reported transactions

  2. 2

    Danielle Louise Cobb

    $1,522.30 across 10 reported transactions

  3. 3

    Daryl S Marx

    $1,504.22 across 12 reported transactions

  4. 4

    Carlos Egas

    $1,422.76 across 20 reported transactions

  5. 5

    Karl Andrew LeBlanc

    $1,273.46 across 10 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as TAS Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about TAS Medical, Inc..

Sumitomo Pharma Co., Ltd.

HHI 2292

Scientia Vascular

HHI 2293

Advanced Oxygen Therapy Inc.

HHI 2288

Mizuho America, Inc.

HHI 2287

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with TAS Medical, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download TAS Medical, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.